» Articles » PMID: 28668522

The Traumatic Bone: Trauma-induced Heterotopic Ossification

Overview
Journal Transl Res
Publisher Elsevier
Specialty Pathology
Date 2017 Jul 3
PMID 28668522
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Heterotopic ossification (HO) is a common occurrence after multiple forms of extensive trauma. These include arthroplasties, traumatic brain and spinal cord injuries, extensive burns in the civilian setting, and combat-related extremity injuries in the battlefield. Irrespective of the form of trauma, heterotopic bone is typically endochondral in structure and is laid down via a cartilaginous matrix. Once formed, the heterotopic bone typically needs to be excised surgically, which may result in wound healing complications, in addition to a risk of recurrence. Refinements of existing diagnostic modalities, like micro- and nano-CT are being adapted toward early intervention. Trauma-induced HO is a consequence of aberrant wound healing, systemic and local immune system activation, infections, extensive vascularization, and innervation. This intricate molecular crosstalk culminates in activation of stem cells that initiate heterotopic endochondral ossification. Development of animal models recapitulating the unique traumatic injuries has greatly facilitated the mechanistic understanding of trauma-induced HO. These same models also serve as powerful tools to test the efficacy of small molecules which specifically target the molecular pathways underlying ectopic ossification. This review summarizes the recent advances in the molecular understanding, diagnostic and treatment modalities in the field of trauma-induced HO.

Citing Articles

Network study of miRNA regulating traumatic heterotopic ossification.

Lian K, Chen Z, Chen L, Li Y, Liu L PLoS One. 2025; 20(2):e0318779.

PMID: 39932915 PMC: 11813146. DOI: 10.1371/journal.pone.0318779.


Osteoblastic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells on P3HT Thin Polymer Film.

Campione P, Rizzo M, Bauso L, Ielo I, Messina G, Calabrese G J Funct Biomater. 2025; 16(1).

PMID: 39852566 PMC: 11765816. DOI: 10.3390/jfb16010010.


Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets.

Li J, Dang Y, Liu M, Gao L, Lin H Int J Biol Sci. 2025; 21(2):544-564.

PMID: 39781450 PMC: 11705629. DOI: 10.7150/ijbs.102297.


Heterotopic ossification following severe radial head fractures: Clinical outcome and associated factors.

Fischer C, Porsche J, Leyder D, Schull D, Histing T, Ziegler P Jt Dis Relat Surg. 2024; 36(1):47-55.

PMID: 39719901 PMC: 11734851. DOI: 10.52312/jdrs.2025.1992.


Mast cell activation by NGF drives the formation of trauma-induced heterotopic ossification.

Jiang T, Ao X, Xiang X, Zhang J, Cai J, Fu J JCI Insight. 2024; 10(1.

PMID: 39589893 PMC: 11721298. DOI: 10.1172/jci.insight.179759.


References
1.
Chidel M, Suh J, Matejczyk M . Radiation prophylaxis for heterotopic ossification of the knee. J Arthroplasty. 2001; 16(1):1-6. DOI: 10.1054/arth.2001.16492. View

2.
Taly A, NAIR K, Jayakumar P, Ravishankar D, Kalaivani P, Indiradevi B . Neurogenic heterotopic ossification : a diagnostic and therapeutic challenge in neurorehabilitation. Neurol India. 2001; 49(1):37-40. View

3.
Gannon F, Glaser D, Caron R, Thompson L, Shore E, Kaplan F . Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol. 2001; 32(8):842-8. DOI: 10.1053/hupa.2001.26464. View

4.
Ledermann H, Schweitzer M, Morrison W . Pelvic heterotopic ossification: MR imaging characteristics. Radiology. 2002; 222(1):189-95. DOI: 10.1148/radiol.2221010552. View

5.
Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen D . Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev. 2002; 111(1-2):61-73. DOI: 10.1016/s0925-4773(01)00601-3. View